Prolyl Hydroxylase Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/US2007/071854, filed Jun 22, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,557,834 | Prolyl Hydroxylase Inhibitors In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | ||
| US 8,815,884 | Prolyl Hydroxylase Inhibitors In force · Medium confidence | GlaxoSmithKline LLC | In force | Medium confidence | ||
| US 10,035,779 | Prolyl Hydroxylase Inhibitors In force · Medium confidence | GlaxoSmithKline, LLC | In force | Medium confidence | ||
| US 10,336,711 | Prolyl Hydroxylase Inhibitors In force · Medium confidence | GlaxoSmithKline, LLC | In force | Medium confidence | ||
| US 11,643,397 | Prolyl Hydroxylase Inhibitors In force · Medium confidence | GlaxoSmithKline LLC | In force | Medium confidence | ||
| US 8,324,208 | Prolyl Hydroxylase Inhibitors In force · High confidence | GlaxoSmithKline LLC | In force | High confidence | ||
| Application 14/335,206 | Prolyl Hydroxylase Inhibitors Abandoned Abandoned Nov 16, 2015 | GlaxoSmithKline LLC | Abandoned | Abandoned Nov 16, 2015 | ||
| Application 14/791,152 | Prolyl Hydroxylase Inhibitors Abandoned Abandoned Jun 21, 2016 | GlaxoSmithKline LLC | Abandoned | Abandoned Jun 21, 2016 | ||
| Application 16/455,106 | Prolyl Hydroxylase Inhibitors Abandoned Abandoned Jul 27, 2021 | GlaxoSmithKline, LLC | Abandoned | Abandoned Jul 27, 2021 | ||
| Application 18/187,211 | Prolyl Hydroxylase Inhibitors Abandoned Abandoned Feb 25, 2024 | GlaxoSmithKline LLC | Abandoned | Abandoned Feb 25, 2024 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.